Afleveringen
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria SalemNew Strategies for Curative Therapies for Diabetes – Prof. Stefan BornsteinUpdate on Efforts to Interdict Type 1 Diabetes – Dr. Desmond SchatzThis episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.
Join us as we summarize key takeaways from these thought-provoking presentations:
View – Dr. Anders CarlsonCounterview – Dr. Jeremy Pettus Rebuttal by Speaker Presenting View – Dr. Anders CarlsonRebuttal by Speaker Presenting Counterview – Dr. Jeremy PettusThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
https://attd.kenes.com
-
Zijn er afleveringen die ontbreken?
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.
Join us as we summarize key takeaways from these thought-provoking presentations:
View – Prof. Jennifer SherrCounterview – Dr. Steven EdelmanRebuttal by Speaker Presenting View – Prof. Jennifer SherrRebuttal by Speaker Presenting Counterview – Dr. Steven EdelmanThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.
Join us as we summarize key takeaways from these thought-provoking presentations:
Artificial Intelligence (AI) for Diabetes Treatment: A Next Step of Systematic Review and Network Meta-Analyses? – Prof. Oliver SchnellData-Driven Machine Learning: Unlocking the Future of Closed-Loop Diabetes Care – Prof. Yao QinMultiomics Biomarkers for Improved Diagnosis of Endocrine Hypertension – Prof. Maria-Christina ZennaroThis episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.
Join us as we summarize key takeaways from these thought-provoking presentations:
Yes, We Should Continue with Placebo – Prof. Colin DayanNo, We Should Use Only Active (Approved) Control – Dr. Laura JacobsenRebuttal by Speaker Presenting the Case for 'Yes' – Prof. Colin DayanRebuttal by Speaker Presenting the Case for 'No' – Dr. Laura JacobsenThis episode is an essential listen for researchers, clinicians, and diabetes specialists interested in the future of clinical trial design, the ethical considerations in testing new treatments, and the evolving landscape of type 1 diabetes research.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of technology and AI in addressing these disparities, and the need for personalized treatment approaches for women with diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
Leveraging Technology to Address Gender Differences in Diabetes – Prof. Eda Cengiz The Role of Estradiol in Energy and Glucose-Insulin Homeostasis – Dr. Lia Bally Impact of Sex on the Control of Type 2 Diabetes – Prof. Chiara FabrisSex Differences in Diabetes Management in the Primary Care Setting – Dr. Natalie BelliniSex Differences in Cardiovascular Risk Factors in Youth with Type 1 Diabetes – Dr. Darja Šmigoc SchweigerThis episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers who are looking to gain insights into the latest gender-specific approaches in diabetes management and how to leverage technology to improve patient outcomes for women with diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.
Join us as we summarize key takeaways from these thought-provoking presentations:
SGLT2i Use in Young People Following Approval by FDA and EMA in Type 2 Diabetes – Dr. Lori LaffelDo Different Types of Prediabetes Require Different Types of Prevention Approaches? – Dr. Viswanathan MohanUse of CGM in Pre-Type 2 Diabetes – Prof. Viral ShahThis episode is an essential listen for endocrinologists, diabetes care specialists, healthcare providers, and researchers focusing on innovative, patient-centered approaches to managing type 2 diabetes and pre-diabetes, aimed at improving both clinical outcomes and patient experiences.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabetes management, enhancing patient autonomy, and supporting healthcare providers in delivering personalized care.
Join us as we summarize key takeaways from these thought-provoking presentations:
Decision Support Systems for Healthcare Providers and People with Diabetes – Prof. Revital NimriSpotlight-AQ: Harnessing AI to Deliver the First Step in the Precision Medicine Pathway – Prof. Katharine Barnard-KellyAI Bolus Calculator for People on Multiple Daily Injections – Prof. Anas El FathiCan Decision Support for Evaluating AID Uploads Assist Clinicians? – Prof. Kirsten NørgaardThis episode is an essential listen for endocrinologists, diabetes specialists, AI innovators, and healthcare providers looking to explore the evolving role of decision support technologies in improving diabetes care, patient outcomes, and clinical efficiency.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
ATTD 2025, the 18thInternational Conference on Advanced Technologies & Treatments forDiabetes, is taking place on March 19-22, 2025, in Amsterdam.
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Fully Closed-Loop: A New Era of Control, featuring cutting-edge advancements in machine learning–driveninsulin delivery systems and their potential to transform diabetes management across everyday life, exercise, meals, and clinical settings.
Join us as we summarize key takeaways from these thought-provoking presentations:
Machine Learning– The Key to Fully Automated Closed-Loop – Prof. Boris KovatchevMeal Compositions and Postprandial Glycemic Management in FullyClosed-Loop Systems – Dr. Laya Ekhlaspour Fully Closed-Loop: From Announced to Unannounced Exercise – Prof.Othmar MoserPerioperative Closed-Loop Use During Major Surgery – Dr. Lia BallyThis episode is an essential listen for endocrinologists, diabetes specialists, clinicians, and healthcare professionals involved in insulin therapy, looking to stay at the forefront of automated systems and machine learning technologies that are reshaping the future of diabetes management.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Use of Technology in Pregnancy, featuring innovative discussions on the challenges of managing diabetes during pregnancy, the impact of hybrid closed-loop and insulin delivery systems on glycemic control, and the need for individualized care to optimize outcomes for both mothers and babies.
Join us as we summarize key takeaways from these thought-provoking presentations:
How Do You Know That Your Pregnant Woman with Diabetes is Well Controlled? – Prof. Yariv YogevUse of the Medtronic 780G Hybrid Closed-Loop System in Type 1 Diabetes Pregnancy – Prof. Katrien BenhalimaThe Role of CamAPS FX in T1D Pregnancy – Prof. Helen MurphyReal-World Experience of Hybrid Closed-Loop Use During Type 1 Diabetes Pregnancy: A Spanish Perspective – Dr. Rosa CorcoyThis episode is an essential listen for obstetricians, endocrinologists, diabetes specialists, and healthcare professionals involved in managing pregnant women with diabetes. Learn about the latest advances in diabetes technology and how to apply them for optimal outcomes during pregnancy.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Time in Tight Glycemic Range: A Crucial Goal or an Unnecessary Burden?, featuring an in-depth exploration of the complexities behind glycemic control, the challenges of achieving tight ranges, and the need for personalized, accessible diabetes management strategies.
Join us as we summarize key takeaways from these thought-provoking presentations:
Time in Tight Glycemic Range: Overview of the Physiological Data – Dr. Anders Carlson Qualitative Data Perspective – Dr. Molly Tanenbaum Health Inequalities Perspective – Dr. David Kerr PwD Perspective – Ms. Julie HeverlyThis episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers looking to understand the physiological, social, and practical complexities of achieving tight glycemic control and how to better support personalized diabetes management.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
Closed-loop from Diagnosis: What Have We Learned from the Longest-Ever Closed-Loop Study - Dr. Charlotte Boughton NAP @ Home: First Outpatient Studies of Neural-net Artificial Pancreas -Dr. Laya Ekhlaspour Cam APS FX in Very Young Children in Italy; 2-Year Follow-Up - Prof. Marco Marigliano How Do I See the Future of AID? - Prof. Roman HovorkaThis episode is an essential listen for healthcare professionals and researchers in the field of diabetes care, looking to stay updated on the latest advancements in closed-loop insulin delivery systems, as well as their future potential for improving glycemic control and quality of life for patients with type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into the ATTD Yearbook Session, featuring a dynamic review of the year’s most impactful advances in diabetes technology, therapies, and care delivery—from AI-driven insulin systems to digital health, telemedicine, and emerging treatments across all ages and care settings.
Join us as we summarize key takeaways from these thought-provoking presentations:
Virtual Clinics for Diabetes Care – Prof. Satish Garg Continuous and Intermittent Glucose Monitoring in 2024 – Dr. Klemen Dovč Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan LalNew Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester Closed-Loop, Artificial Intelligence-Based Decision Support Systems and Data Science – Prof. Revital Nimri Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman Technology and Pregnancy – Prof. Helen Murphy Diabetes Technology and Therapy in the Pediatric Age Group – Dr. David Maahs Advances in Exercise and Nutrition as Therapy in Diabetes – Dr. Dessi Zaharieva Primary Care and Diabetes Technologies and Treatments – Dr. Gregg Simonson Use of Technologies at the Advanced Age – Prof. Tali Cukierman-Yaffe Diabetes Technology in the “Real World”: Expanding Access and Addressing Disparities – Dr. Stuart Weinzimer Diabetes Technology in the Hospital – Dr. Francisco Pasquel Diabetes Technology and the Human Factor – Dr. Alon Liberman Immune Interventions and Restorative Therapies in Type 1 Diabetes – Dr. Laura Jacobsen New Medications for the Treatment of Diabetes – Prof. Irl Hirsch Obesity and Diabetes – Prof. Viral Shah Emerging Trends in MAFLD and MASH – Dr. Samita GargThis episode is an essential listen for diabetes clinicians, researchers, digital health innovators, and healthcare leaders looking to stay informed on the biggest developments of the past year in diabetes care—across clinical practice, digital transformation, and therapeutic innovation.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD Conference Catch-Up, we dive into Pediatric Obesity: Current Challenges and Future Directions, featuring a comprehensive look at the genetic, environmental, and therapeutic factors shaping the future of pediatric obesity management.
Join us as we summarize key takeaways from these thought-provoking presentations:
A Holistic Approach to Understanding Childhood Obesity – Prof. Antje KörnerAdvances in Pharmacological Interventions for Pediatric and Adolescent Obesity – Current Status and Future Prospects – Dr. Jamie MatuTherapy for Monogenic Obesity – Prof. Primož KotnikThis episode is an essential listen for pediatric endocrinologists, obesity specialists, diabetes care teams, and healthcare professionals working with children and adolescents, looking to understand the latest science and strategies to combat pediatric obesity—ranging from individualized treatment for monogenic obesity to emerging pharmacological therapies and multidisciplinary care approaches.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19–22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Artificial Intelligence (AI) Technology for Diabetes, featuring explorations of AI's role in predicting complications, enhancing automated insulin delivery, and advancing personalized diabetes management.
Join us as we summarize key takeaways from these thought-provoking presentations:
Machine Learning Methods Predicting Diabetes Complications – Dr. Riccardo Bellazzi Applications of Generative AI to Diabetes – Prof. Josep Vehi AI-Enabled Meal Detection and Dosing in Automated Insulin Delivery Systems – Dr. Peter Jacobs AI Takes Diabetes Management Beyond AID – Dr. Deborah WakeThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals keen on harnessing AI technologies for improving diabetes care, from predicting complications to optimizing automated insulin delivery and personalizing treatment plans.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) in Type 2 Diabetes, featuring discussions on the impact of CGM on glycemic control, cost-effectiveness, and its integration with lifestyle interventions and medications for improved diabetes management.
Join us as we summarize key takeaways from these thought-provoking presentations:
Real World Data on CGM in Type 2 Diabetes - Glucose Control Improvement – Dr. Richard Bergenstal Glycemic Excursion Minimization (GEM): A Lifestyle Intervention for the Management of Type 2 Diabetes – Prof. Chiara Fabris Cost Benefits of CGM Use in Type 2 Diabetes – Dr. Roy Beck CGM-Based Intensification and De-Intensification of Therapy in Type 2 Diabetes – Prof. Irl HirschThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals focused on Type 2 diabetes management, looking to learn more about the role of CGM in optimizing treatment plans, improving glycemic control, and managing healthcare costs.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Obesity and Type 1 Diabetes: Tailoring Treatment, featuring insights on the prevalence, pharmacotherapy, and lifestyle strategies for managing obesity in individuals with Type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
Prevalence of Obesity in Type 1 Diabetes – Prof. Shlomit Shalitin Newer GLP Analogs for Treatment of Obesity in Type 1 Diabetes – Prof. Satish Garg Use of GLP1 Analogs in Youth with Type 1 Diabetes for Weight Management in Youth – Dr. Lori Laffel Changing Behaviors to Manage Weight in Children and Adolescents with Type 1 Diabetes – Dr. Carmel SmartThis episode is an essential listen for endocrinologists, pediatricians, diabetes specialists, and healthcare professionals focusing on the intersection of obesity management and Type 1 diabetes, seeking to optimize treatment strategies for this complex condition.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Digital Twins and Artificial Intelligence, featuring cutting-edge applications of digital twins and AI to simulate patient-specific scenarios and optimize personalized treatment strategies in diabetes care.
Join us as we summarize key takeaways from these thought-provoking presentations:
Creating Digital Twins: Model-Driven and AI Methods – An Introduction – Prof. Giacomo Cappon How Digital Twins Can Enhance Clinical Trials – Prof. Boris Kovatchev Digital Twins, Replay Simulation, and Decision Support – Prof. Anas El Fathi AI Analytics and CGM Data Science – Dr. Clara Mosquera-LopezThis episode is an essential listen for endocrinologists, diabetes researchers, AI specialists, and healthcare professionals looking to stay ahead of the curve in using AI and digital twin technologies for personalized diabetes management and treatment optimization.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Adult Obesity: Causes, Risks, and Management Strategies, featuring insights on the SELECT trial, GLP-1 receptor agonists, and innovative approaches to managing obesity, Type 2 diabetes, and metabolic liver diseases.
Join us as we summarize key takeaways from these thought-provoking presentations:
Lessons from the SELECT Trial: Rethinking the Clinical Applications for the GLP-1RA Semaglutide – Prof. Donna Ryan Heterogeneity of Obesity and Type 2 Diabetes – Prof. Ewan Pearson Incretin-Based Therapies for the Treatment of Obesity-Related Diseases – Prof. Francesco Giorgino Prevalence and Rationale for New Terminologies in NAFLD – Dr. Samita GargThis episode is an essential listen for endocrinologists, diabetes specialists, obesity researchers, and healthcare professionals looking to stay informed about the latest therapeutic strategies for managing obesity and metabolic diseases, with a focus on clinical applications and emerging terminologies.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
-
In this episode of ATTD 2025 Conference Catch-Up, we dive into Beta Cell Therapies for Type 1 Diabetes, featuring innovative discussions on regenerative therapies, stem cell approaches, and novel treatments to protect and regenerate beta cells in the fight against Type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
Human Beta Cell Regenerative Drug Therapy: A Journey from Impossible to Possible – Dr. Andrew Stewart Optimizing Differentiation and Engraftment of Stem Cell-Derived Islets for Type 1 Diabetes Treatment – Dr. Maria Cristina Nostro Optimizing Stem Cell-Derived Beta Cell Function for Transplantation – Prof. Matthias Hebrok Novel Type 1 Diabetes Therapies Targeting Endogenous Islet Cells – Prof. Anath ShalevThis episode is an essential listen for endocrinologists, diabetes researchers, stem cell scientists, and healthcare professionals looking to stay on top of the latest advancements in beta cell regeneration and transplantation therapies for Type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com
- Laat meer zien
